Q2 2025 Earnings Call Transcript August 13, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.07, ...

ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock split proposal - - Webcast to begin at 4:30 p.m. ET / 1:30 p.m. PT - SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

Vaxart Inc (VXRT) reports a significant revenue increase but faces hurdles with trial suspensions and NASDAQ compliance ...

Vaxart ( ($VXRT) ) has released its Q2 earnings. Here is a breakdown of the information Vaxart presented to its investors. Vaxart, Inc. is a ...

Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs, supporting potential for improved protection against infection   ...